GR
Annual Report and Accounts 2024/25
Total income £140.4m in 2024/25 — record third consecutive year; £61.6m from direct gifts; £29.9m from legacies; 90,000+ new committed givers joined in year
Key Metric 1
First-ever targeted treatment for children's brain tumours approved for NHS following decades of GOSH Charity-funded research — alternative to chemotherapy now available; Children's Cancer Centre main works contract milestones reached; deconstruction work began February 2025